| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.00057 | 1 |